You are here: Welcome to the MPKB » Welcome to the MPKB » Diseases » Inflammatory bowel disease (Crohn's disease and ulcerative colitis)
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:diseases:ibd [02.17.2019] – [Inflammatory bowel disease (Crohn's disease and ulcerative colitis)] sallieqhome:diseases:ibd [03.21.2019] – [Research] sallieq
Line 181: Line 181:
  
 ===== Research ===== ===== Research =====
 +
 +Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely.  (({{pubmed>long:25023670}}))
 +
 +In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.   (({{pubmed>long:25947920}}))
  
 Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.  (({{pubmed>long:25557335}}))  Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.  (({{pubmed>long:25557335}})) 
Line 194: Line 198:
 'Western'-style diets, high in fat/sugar, low in fibre, decrease beneficial Firmicutes that metabolise dietary plant-derived polysaccharides to SCFAs and increase mucosa-associated Proteobacteria (including enteric pathogens).   (({{pubmed>long:26011307}}))  'Western'-style diets, high in fat/sugar, low in fibre, decrease beneficial Firmicutes that metabolise dietary plant-derived polysaccharides to SCFAs and increase mucosa-associated Proteobacteria (including enteric pathogens).   (({{pubmed>long:26011307}})) 
  
-[[https://www.sciencemag.org/news/2018/11/do-gut-bacteria-make-second-home-our-brains|Roberts doesn’t know how these bacteria could have gotten into the brain. They may have crossed from blood vessels, traveling up nerves from the gut, or even come in through the nose]]+Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease.  [[https://jmm.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.017541-0#tab2|microbiology research]] 
 + 
 +Butyric acid in functional constipation   (({{pubmed>long:24868272}})) 
 + 
 +Butyric acid in irritable bowel syndrome  (({{pubmed>long:24868283}}))
      
  
 +  
 +
 +[[https://www.sciencemag.org/news/2018/11/do-gut-bacteria-make-second-home-our-brains|Roberts doesn’t know how these gut bacteria could have gotten into the brain. They may have crossed from blood vessels, traveling up nerves from the gut, or even come in through the nose]]
 +  
 +[[https://www.karger.com/Article/FullText/477386|Resistant Starch Regulates Gut Microbiota: Structure, Biochemistry and Cell Signalling]]
 +
 +
 +[{{:home:diseases:file:table_1_yang_et_al.gif|**Table 1  Yang et al **}}]
 =====  Patient interviews  ===== =====  Patient interviews  =====
  
home/diseases/ibd.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.